✦ LIBER ✦

Transarterial Embolization and Doxorubicin Eluting Beads-Transarterial Chemoembolization (DEB-TACE) of Malignant Extra-Adrenal Pheochromocytoma

✍ Scribed by Pradesh Kumar; Timothy Bryant; David Breen; Brian Stedman; Nigel Hacking

Book ID: 105985812
Publisher: Springer
Year: 2011
Tongue: English
Weight: 543 KB
Volume: 34
Category: Article
ISSN: 1432-086X
DOI: 10.1007/s00270-011-0137-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of doxorubicin-eluting bead t

Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma

✍ M.D. Ferrer Puchol; C. la Parra; E. Esteban; M. Vaño; M. Forment; A. Vera; O. Co 📂 Article 📅 2011 🏛 Elsevier ⚖ 254 KB

Comparison of conventional transarterial

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

✍ Renumathy Dhanasekaran; David A. Kooby; Charles A. Staley; John S. Kauh; Vinit K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Background and Objectives Chemoembolization with doxorubicin drug eluting beads (DEB) is a novel locoregional treatment modality for unresectable hepatocellular carcinoma (HCC). Initial animal studies and clinical trials suggest that treatment with DEB may provide safer and more eff

Abstract No. 213: Quality of life assess

Abstract No. 213: Quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC)

✍ Webber, G.; Rivas, M.V.; Chen, Z.; Nichols, L.; El-Rayes, B.; Kim, H.S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Update with longitudinal analysis of qua

Update with longitudinal analysis of quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC)

✍ Webber, G.; Chen, Z.; El-Rayes, B.; Kauh, J.; Spivey, J.R.; Hanish, S.I.; Kim, H 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Update with longitudinal analysis of qua

Update with longitudinal analysis of quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC)

✍ Webber, G.; Chen, Z.; El-Rayes, B.; Kauh, J.; Spivey, J.R.; Hanish, S.I.; Kim, H 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Abstract No. 219: Correlation of surviva

Abstract No. 219: Correlation of survival and tumor response with WHO, RECIST, EASL and mRECIST criteria after doxorubicin drug eluting beads transarterial chemoembolization (DEB TACE) in unresectable hepatocellular carcinoma (HCC)

✍ Prajapati, H.J.; Chen, Z.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB